DNMT1 and hepatocellular carcinoma: Furthermore, Kaplan-Meier analysis revealed that the three-year recurrence-free survival rate was significantly lower for HCC patients in the strongly positive DNMT1 group as compared with that in the DNMT1-negative HCC patients (Fig. 3D; P=0.002).